Chest
-
DVT/PE PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: In this retrospective study, we compare the meterological parameters between the patients who had risk factors and idiopatic pulmonary embolism (PE) patients. We looked for seasonal variations in the incidence of idiopathic PE and a relationship with atmospheric pressure, humidity, or temperature. ⋯ The following authors have nothing to disclose: Tuba Inal, Ceyda Anar, Ipek Unsal, Gülru Polat, Hüseyin HalilçolarNo Product/Research Disclosure Information.
-
Respiratory Infections PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Chest imaging 4-8 weeks following diagnosis of community-acquired pneumonia (CAP) is a routine and historically recommended practice. There is insufficient data to support this practice and the most recent recommendations are mute on the subject. This study examines the real-world practice of chest imaging following CAP; the rate persistent radiographic abnormalities; and the association of persistent abnormalities with clinical risk factors and subsequent non-malignant and malignant pulmonary diseases. ⋯ The following authors have nothing to disclose: Luke Surry, Michael Morris, William HannahNo Product/Research Disclosure Information.
-
Pleural Disease/Pleural Effusion PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To find biochemical parameters in pleural fluid, that may exceed the performance of Light criteria to discriminate transudates and exudates. Assess whether the clinical diagnosis exceeds or not biochemical parameters of pleural fluid to differentiate transudates and exudates. ⋯ The following authors have nothing to disclose: Carolina Gotera, Deisy Barrios Barreto, Patricia Lazo Meneses, Rosa Mirambeaux Villalona, Carolina Jurkojc Mohremberger, Esteban Perez Rodriguez, Salvador Diaz Lobato, Sagrario Mayoralas AlisesNo Product/Research Disclosure Information.
-
Cancer Case Report Posters IISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Primary paraganglioma of the lung is a rare tumor of which few cases are reported in literature. ⋯ The following authors have nothing to disclose: Giuseppe Fiorentino, Anna Annunziata, Rosa Cauteruccio, Raffaele Cobuccio, Mario CaputiNo Product/Research Disclosure Information.
-
Pulmonary Vascular Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Klippel-Trenaunay-Weber syndrome (KTWS) is a rare congenital condition characterized by extensive venous malformations and soft tissue and bone hypertrophy. KTWS predisposes to hypercoagulable states, including venous thromboembolism (VTE) and pulmonary embolism (PE). The incidence of PE ranges from 14-22 %; however, recurrent massive PE is unusual. We report the case of an adult female with KTWS who developed recurrent massive PE and was successfully treated with thrombolytic therapy. ⋯ This rare congenital condition and associated complications can at times be difficult to manage. The management of prophylaxis for PE recurrence is an area that needs special attention.Reference #1: Adriane Gianlupi, MD; Richart W. Harper, MD; Denis M. Dwyre, MD; Gregory P. Marelich, MD, FCCP, "Recurrent Pulmonary Embolism Associated With Klippel-Trenaunay-Weber Syndrome" Chest. 1999;115(4):1199-1201. doi:10.1378/chest.115.4.1199Reference #2: Erin E. Huiras, MD, Cheryl J. Barnes, MD, Lawrence F. Eichenfield, MD, Andrew N. Pelech, MD, Beth A. Drolet, MD, "Pulmonary Thromboembolism Associated With Klippel-Trenaunay Syndrome" Published online September 15, 2005 PEDIATRICS Vol. 116 No. 4 October 1, 2005 pp. e596 -e600Reference #3: Mikula, N, Gupta, SM, Miller, M, et al Klippel-Trenaunay-Weber syndrome with recurrent pulmonary embolism.Clin Nucl Med1991;16,253-255DISCLOSURE: The following authors have nothing to disclose: Abhay Vakil, Khalid Sherani, Viral Patel, Kelly Cervellione, Mohammed BaburyNo Product/Research Disclosure Information.